These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2282971)

  • 1. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
    Kazmierczak A; Cordin X; Duez JM; Siebor E; Pechinot A; Sirot J
    J Int Med Res; 1990; 18 Suppl 4():67D-77D. PubMed ID: 2282971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H
    Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
    Kitzis MD; Ferré B; Coutrot A; Acar JF; Gutmann L
    Eur J Clin Microbiol Infect Dis; 1989 Sep; 8(9):783-8. PubMed ID: 2556277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME; Fu KP; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
    Moosdeen F; Keeble J; Williams JD
    Rev Infect Dis; 1986; 8 Suppl 5():S562-8. PubMed ID: 3026004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
    Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
    Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming enzymatic resistance in bacteria: impact on future therapy.
    Labia R; Barthélémy M; Péduzzi J; Morand A; Tiwari K; Kazmierczak A
    J Int Med Res; 1990; 18 Suppl 4():48D-57D. PubMed ID: 2282969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of clavulanic acid sulbactam on induction of class 1 beta-lactamase.
    Farmer TH; Reading C
    J Chemother; 1989 Jul; 1(4 Suppl):331-3. PubMed ID: 16312426
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolution of beta-lactamase inhibitors.
    Jackson D
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
    Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of a sulphone beta-lactamase inhibitor, YTR 830.
    Moosdeen F; Williams J; Yamabe S
    Chemioterapia; 1987 Jun; 6(2 Suppl):206-7. PubMed ID: 2855613
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates.
    Perilli M; Felici A; Oratore A; Cornaglia G; Bonfiglio G; Rossolini GM; Amicosante G
    Antimicrob Agents Chemother; 1996 Mar; 40(3):715-9. PubMed ID: 8851599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC; Barry AL
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.
    Bush K; Flamm RK; Ohringer S; Singer SB; Summerill R; Bonner DP
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination].
    Aubert G; Peyle V; Dumont N; el Fassi M; Dorche G
    Ann Biol Clin (Paris); 1990; 48(7):449-54. PubMed ID: 2278408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
    Moittie D; Simonet M; Veron M
    Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of clavulanic acid and sulbactam on beta-lactamase biosynthesis.
    Farmer TH; Reading C
    J Antimicrob Chemother; 1988 Aug; 22(2):105-11. PubMed ID: 3263350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus].
    Kitzis MD; Goldstein FW; Labia R; Acar JF
    Ann Microbiol (Paris); 1983; 134A(2):163-8. PubMed ID: 6307103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.